Related Experiment Video
Updated: Aug 5, 2025

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
Published on: February 10, 2023
Gastrointestinal microbiome and cholelithiasis: Current status and perspectives.
Wan-Yue Dan1,2, Yun-Sheng Yang1, Li-Hua Peng1
1Microbiota Division, Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
The gastrointestinal (GI) microbiome influences gallstone formation (cholelithiasis). Microbiota alterations and dysbiosis are linked to gallstone development and bile acid metabolism.
Area of Science:
- Gastroenterology and Microbiology
Background:
- Cholelithiasis affects 10-15% of adults, posing global health and financial burdens.
- Its pathogenesis is multifactorial, involving genetics, hepatic factors, and the gastrointestinal (GI) microbiome.
- The GI microbiome's role in cholelithiasis is increasingly recognized, particularly concerning bile acid metabolism.
Purpose of the Study:
- To review the literature on the GI microbiome's involvement in cholelithiasis.
- To explore the association between microbiota dysbiosis and gallstone formation.
- To discuss the influence of GI microbiome alterations on cholelithogenesis.
Main Methods:
- Literature review of high-throughput sequencing studies.
- Analysis of research on bile, gallstones, and fecal microbiome in cholelithiasis.
- Examination of studies linking microbiota to bile acid metabolism and signaling pathways.
Main Results:
- High-throughput sequencing implicates the GI microbiome in cholelithiasis.
- Microbiota dysbiosis is associated with gallstone formation.
- The GI microbiome influences cholelithogenesis via bile acid metabolism.
Conclusions:
- The GI microbiome plays a significant role in the pathogenesis of cholelithiasis.
- Understanding microbiome alterations is crucial for elucidating gallstone formation.
- Targeting the GI microbiome may offer new therapeutic strategies for cholelithiasis.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
